Home Cart Sign in  
Chemical Structure| 32926-43-5 Chemical Structure| 32926-43-5
Chemical Structure| 32926-43-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Boc-His(Trt)-OH is a histidine derivative widely used as a protecting group in peptide synthesis.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Boc-His(Trt)-OH

CAS No. :32926-43-5
Formula : C30H31N3O4
M.W : 497.58
SMILES Code : O=C(O)[C@H](CC1=CN(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1)NC(OC(C)(C)C)=O
MDL No. :MFCD00153307
InChI Key :OYXZPXVCRAAKCM-SANMLTNESA-N
Pubchem ID :13968084

Safety of Boc-His(Trt)-OH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of Boc-His(Trt)-OH

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 32926-43-5 ]

[ 32926-43-5 ] Synthesis Path-Downstream   1~36

  • 2
  • [ 134334-91-1 ]
  • [ 32926-43-5 ]
  • [(S)-1-[(1S,2R)-1-Cyclohexylmethyl-3,3-difluoro-2-hydroxy-3-(2-morpholin-4-yl-ethylcarbamoyl)-propylcarbamoyl]-2-(1-trityl-1H-imidazol-4-yl)-ethyl]-carbamic acid tert-butyl ester [ No CAS ]
  • 4
  • [ 24424-99-5 ]
  • [ 35146-32-8 ]
  • [ 32926-43-5 ]
  • 5
  • [ 62697-87-4 ]
  • [ 32926-43-5 ]
  • 6
  • {3-[(2'-{2-[(2S,3R)-2-((2S,3S,4R)-4-Amino-3-hydroxy-2-methyl-pentanoylamino)-3-hydroxy-butyrylamino]-ethyl}-[2,4']bithiazolyl-4-carbonyl)-amino]-propyl}-dimethyl-sulfonium [ No CAS ]
  • [ 32926-43-5 ]
  • [ 176752-33-3 ]
  • 9
  • [ 771-61-9 ]
  • [ 32926-43-5 ]
  • [ 396728-17-9 ]
  • 10
  • [ 123-75-1 ]
  • [ 32926-43-5 ]
  • [2-oxo-2-pyrrolidin-1-yl-1-(1-trityl-1<i>H</i>-imidazol-4-ylmethyl)-ethyl]-carbamic acid <i>tert</i>-butyl ester [ No CAS ]
  • 11
  • [ 110-89-4 ]
  • [ 32926-43-5 ]
  • [2-oxo-2-piperidin-1-yl-1-(1-trityl-1<i>H</i>-imidazol-4-ylmethyl)-ethyl]-carbamic acid <i>tert</i>-butyl ester [ No CAS ]
  • 12
  • [ 32926-43-5 ]
  • 1-(L-histidyl)pyrrolidine bistrifluoroacetate [ No CAS ]
  • 13
  • [ 32926-43-5 ]
  • 1-(L-histidyl)piperidine bistrifluoroacetate [ No CAS ]
  • 14
  • [ 32926-43-5 ]
  • L-histidine(2,3-dilauryloxy)propylamide [ No CAS ]
  • 15
  • [ 32926-43-5 ]
  • L-histidine(2-lauryloxy-3-stearyloxy)propylamide [ No CAS ]
  • 16
  • [ 32926-43-5 ]
  • [ 396728-18-0 ]
  • 17
  • [ 32926-43-5 ]
  • [ 396728-19-1 ]
  • 18
  • [ 76-83-5 ]
  • DL-lysine methyl ester dihydrochloride [ No CAS ]
  • [ 32926-43-5 ]
  • 19
  • [ 40917-50-8 ]
  • [ 32926-43-5 ]
  • 20
  • [ 62715-28-0 ]
  • [ 32926-43-5 ]
  • 21
  • [ 32926-43-5 ]
  • [ 176752-32-2 ]
  • 22
  • [ 32926-43-5 ]
  • [ 176752-34-4 ]
  • 23
  • [ 32926-43-5 ]
  • Nβ-[3(S)-[4-amino-6-[[[1-(S)-[({4(S)-[({1(S)-[({2-[4'-([3-(dimethylsulfonio)-1-propyl]amino}carbonyl)-2',4-bithiazol-2-yl]-1-ethyl}amino)carbonyl]-2(R)-hydroxy-1-propyl}amino)carbonyl]-3(S)-hydroxy-2(R)-pentyl}amino)carbonyl]-2-(imidazol-4-yl)-1-... [ No CAS ]
  • 24
  • [ 71-00-1 ]
  • [ 32926-43-5 ]
  • 25
  • [ 1499-46-3 ]
  • [ 32926-43-5 ]
  • 26
  • [ 14997-58-1 ]
  • [ 32926-43-5 ]
  • 27
  • [ 15545-10-5 ]
  • [ 32926-43-5 ]
  • 28
  • [ 68262-63-5 ]
  • [ 32926-43-5 ]
  • 36
  • [ 32926-43-5 ]
  • [ 835871-00-6 ]
YieldReaction ConditionsOperation in experiment
With caesium carbonate; In DMF (N,N-dimethyl-formamide); water; for 5h; Boc-His (Trt) (25.3 mg) was dissolved in a mixed solvent of DMF (0.5 mL) and water (0.5 mL) in which Cs2CO3 (9.0 mg) had been dissolved, and concentration and drying were carried out under-reduced pressure. The residue was dissolved in DMF (2 ML), and then concentration and drying were again carried out under reduced pressure, and the residue obtained (Boc-His (Trt) OCs) was dried under reduced pressure in a DESSICATOR overnight under the presence of DIPHOSPHORUS pentaoxide. Dried DMF (1 mL) was added to the residue (Boc-His (Trt) OCs) and the residue was dissolved, and then the (CH3) 3CO-OCH2I obtained in (1) above (13 mg) was added to the solution, and the mixture was stirred overnight at room temperature. Next, the reaction solution obtained was subjected to HPLC (with an ODS column) using water-acetonitrile containing 0. 1percent TFA as an eluent, the fraction containing the target compound (Boc-His (TRT)-OCH2-OCO-C (CH3) 3) was isolated using the absorbance at 220 nm as an indicator, and freeze drying was carried out to obtain a powder (19 mg, 61percent yield).
 

Historical Records

Categories